← All trials
NCT05819398
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 10, 2023
- Primary completion
- Nov 7, 2024
- Completion date
- Sep 21, 2028
- First posted
- Apr 19, 2023
- Last posted
- Dec 29, 2023
- Enrollment
- 200
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Boehringer IngelheimLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.